Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

£60,000 Competition to Recognise Innovative Scientists Launched by BBSRC

Published: Friday, July 12, 2013
Last Updated: Friday, July 12, 2013
Bookmark and Share
Innovator of the Year 2014 competition launched by BBSRC to recognise and reward scientist's whose excellent science and innovations are delivering real world impact.

Innovator of the Year 2014, a prestigious competition from the Biotechnology and Biological Sciences Research Council (BBSRC), is now underway to recognise and reward innovation from BBSRC-funded scientists to deliver real-world impacts.

The competition, now in its sixth year, offers a personal award of £30,000 to the overall winner for taking their research beyond the lab to deliver social and economic benefits.

This year winners in the competition's three categories will each take away greater rewards of £15,000 each, up from £10,000 in previous years, with the overall winner receiving an additional £15,000 to make £30,000 in total prize money to support their research, training or other activities promoting economic or social impact.

Applications are open for entries to the competition's three categories of 'Commercial Innovator', 'Social Innovator' and 'Most Promising Innovator', designed to reflect the breadth of the benefits delivered by BBSRC's investment in UK bioscience.

Entry is open to all BBSRC-funded scientists with the deadline for nominations on 19 September and the deadline for applications 6 November. Nominations can be made by simply filling out a form at www.bbsrc.ac.uk/business/impact-incentive/innovator .

A shortlist of finalists will be completed in January 2014, with the winners to be announced in March 2014.

The finalists will be judged by an expert independent panel. The judges will be looking to recognise those innovators who have worked hardest and have gone furthest to take their science out of the lab to deliver impact.

Last year's winner was Dr Ryan Donnelly of Queen's University Belfast who won the Most Promising Innovator and Overall Innovator titles for his work on hydrogel-based microneedles.
Dr Donnelly said: "Winning BBSRC Innovator of the Year has been the highlight of my career to date. To be recognised in this way is something very special.

"From the point of view of progressing my own microneedle technology, I have already had contact from two world players in the pharma industry as a result of my award from BBSRC, with a view to conducting collaborative projects.

"I would thoroughly recommend academics to apply for BBSRC Innovator of the Year, due to enhanced visibility for their work, increased opportunity to network with peers and the real possibility of initiating collaborations."

Professor Douglas Kell, BBSRC Chief Executive, said: "Innovator of the Year has established itself as a highly respected and much anticipated competition. BBSRC funds world class research across the biosciences and translating that work into benefits for society and the economy is incredibly important.

"This is a great chance to recognise the excellent work that BBSRC-funded scientists do to generate impact and I'm very much looking forward to hearing about what I expect will be a very high calibre of entrants this year."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Drugs Used to Treat Lung Disease Work With the Body Clock
Scientists from The University of Manchester have discovered why medication to treat asthma and pneumonia can become ineffective.
Thursday, August 14, 2014
Prions, vCJD and the Immune System Relay
BBSRC is helping to shed new light on variant Creutzfeldt-Jakob disease.
Friday, December 06, 2013
Researchers Have a Nose for How Probiotics Could Affect Hay Fever
A study has shown that a daily probiotic drink changed how cells lining the nasal passages of hay fever sufferers reacted to a single out-of-season challenge.
Thursday, November 28, 2013
New Technique for Developing Drugs
An international team of researchers have created a new drug for possible use against heart disease, inflammation and other illnesses.
Monday, November 18, 2013
Breaking up the Superbugs’ Party
The fight against antibiotic-resistant superbugs has taken a step forward thanks to a new discovery by scientists.
Friday, August 16, 2013
Scientific News
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
Myeloid-Derived Suppressor Cells Play Role in Tumor Growth
Researchers at Baylor College of Medicine have reported a new mechanism that helps cancer cells engage myeloid-derived suppressor cells.
Drug Might Help Treat Sepsis
A DNA enzyme called Top1 plays a key role in turning on genes that cause inflammation in mouse and human cells in response to pathogens. A drug blocking this enzyme rescued mice from lethal inflammatory responses, suggesting a potential treatment for sepsis.
Large-scale HIV Vaccine Trial to Launch in South Africa
NIH-funded study will test safety, efficacy of vaccine regimen.
Immune System Implicated in Gastroschisis
UCSF researchers show that the immune system is implicated in gastroschisis. The findings could lead to improved treatments for the belly birth defect.
Hay Fever's Hidden Supporting Substances
TUM study finds that non-allergenic substances in pollen heighten the immune response.
Cells Carry 'Memory' Of Injury
Researchers from King’s College London show that cells carry a ‘memory’ of injury, which could reveal why chronic pain persists.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!